Recombinant Apyrase (AZD3366) Against Myocardial Reperfusion Injury.
Yochai BirnbaumRegina YeHuan ChenLeif CarlssonCarl WhatlingOla FjellströmErik RybergYumei YePublished in: Cardiovascular drugs and therapy (2022)
AZD3366 attenuated inflammation, necrosis, necroptosis, and pyroptosis and limited IS. The effects of AZD3366 and ticagrelor were additive.